Mylan Sued Over Blood Pressure Drug

Law360, New York (June 4, 2008, 12:00 AM EDT) -- In a move to protect the market for the hypertension drug Azor, Japanese pharmaceutical company Daiichi Sankyo Co. Ltd. on Tuesday hit Mylan Inc. with a patent infringement suit.

Daiichi Sankyo and its U.S.-based unit Daiichi Sankyo Inc. lodged the lawsuit in the U.S. District Court for the District of New Jersey against Mylan and its majority-owned subsidiary Matrix Laboratories Inc.

The Japanese company was responding to an abbreviated new drug application Matrix filed in early 2008 seeking the U.S. Food and Drug Administration's approval to...
To view the full article, register now.